Once Bitten, Merck Halts Cholesterol Drug Study

Imagine a clinical trial of a experimental cholesterol drug that looked an awful lot like a study of a top-selling cholesterol fighter that just turned into a widely publicized debacle for your company. Now throw in the fact that the unapproved cholesterol drug you’re testing in the trial was recently rejected by the FDA. What [...]